Clinical Trial Update: Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the symptomatic effects of nocturnal sodium oxybate in Parkinson's disease with sleep-wake disturbances completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: Christian Baumann | Conditions: Sleep-wake Disturbances in Motor-phase Parkinson's Disease | Phase 2 | Status: COMPLETED